Adq. Farmacos 7
El Instituto Nacional del Cáncer requiere contratar el suministro de los Fármacos 7 necesarios para el óptimo funcionamiento de los servicios clínicos.
16 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 359-3821-SE15 | 31-12-2015 | Novofarma Service S.A. | $173.740 |
| 359-3823-SE15 | 31-12-2015 | Winpharm SpA | $11.424 |
| 359-3822-SE15 | 31-12-2015 | Laboratorio Sanderson S.A. | $49.147 |
| 359-3599-SE15 | 07-12-2015 | Productos Farmoquimicos Roche Limitada | $214.200 |
| 359-3600-SE15 | 05-12-2015 | Laboratorio Sanderson S.A. | $28.084 |
| 359-3594-SE15 | 05-12-2015 | B Braun Medical SpA | $1.142.400 |
| 359-3595-SE15 | 05-12-2015 | Fresenius Kabi Chile Limitada | $3.296.300 |
| 359-3597-SE15 | 05-12-2015 | Novofarma Service S.A. | $104.244 |
| 359-3598-SE15 | 05-12-2015 | Pfizer Chile S.A. | $215.093 |
| 359-3601-SE15 | 05-12-2015 | Aventis Pharma Holding Gmbh | $61.880 |
| 359-3602-SE15 | 05-12-2015 | Synthon Chile Limitada | $286.076 |
| 359-3603-SE15 | 05-12-2015 | Winpharm SpA | $7.616 |
| 359-3240-SE15 | 13-11-2015 | Synthon Chile Limitada | $84.014 |
| 359-3239-SE15 | 13-11-2015 | Aventis Pharma Holding Gmbh | $187.544 |
| 359-3238-SE15 | 13-11-2015 | Productos Farmoquimicos Roche Limitada | $267.750 |
| 359-3237-SE15 | 13-11-2015 | Fresenius Kabi Chile Limitada | $7.563.640 |
| 359-3241-SE15 | 13-11-2015 | Winpharm SpA | $1.904 |
| 359-2798-SE15 | 05-10-2015 | Laboratorio Sanderson S.A. | $35.105 |
| 359-2799-SE15 | 05-10-2015 | Synthon Chile Limitada | $5.712 |
| 359-2797-SE15 | 05-10-2015 | Fresenius Kabi Chile Limitada | $803.250 |
| 359-2439-SE15 | 02-09-2015 | Synthon Chile Limitada | $8.568 |
| 359-1456-SE15 | 02-09-2015 | Abbott Laboratories de Chile Ltda. | $685.440 |
| 359-1457-SE15 | 02-09-2015 | Megalabs Chile S.A. | $64.260 |
| 359-2438-SE15 | 02-09-2015 | Aventis Pharma Holding Gmbh | $61.880 |
| 359-2437-SE15 | 01-09-2015 | Fresenius Kabi Chile Limitada | $2.208.640 |
| 359-2223-SE15 | 21-08-2015 | B Braun Medical SpA | $571.200 |
| 359-2143-SE15 | 11-08-2015 | Fresenius Kabi Chile Limitada | $2.142.000 |
| 359-1462-SE15 | 11-08-2015 | Winpharm SpA | $38.080 |
| 359-2145-SE15 | 11-08-2015 | Synthon Chile Limitada | $81.158 |
| 359-2144-SE15 | 11-08-2015 | Novofarma Service S.A. | $435.219 |
| 359-1461-SE15 | 15-07-2015 | Novofarma Service S.A. | $868.700 |
| 359-1459-SE15 | 15-07-2015 | Aventis Pharma Holding Gmbh | $78.540 |
| 359-1455-SE15 | 15-07-2015 | B Braun Medical SpA | $952.000 |
| 359-1460-SE15 | 15-07-2015 | Synthon Chile Limitada | $78.302 |
| 359-1530-SE15 | 26-06-2015 | Fresenius Kabi Chile Limitada | $10.005.520 |
| 359-1464-SE15 | 19-06-2015 | Fresenius Kabi Chile Limitada | $1.656.480 |
Fuente original:ficha mercadopublico.cl
